HANSA BIOPHARMA AB revenue breakdown overview

HANSA BIOPHARMA AB revenue for the last year amounted to 224.81 M MXN, the most of which — 224.80 M MXN — came from its highest performing source at the moment, Antibody-cleaving Enzyme Technology Platform, the year earlier bringing 287.83 M MXN. The greatest contribution to the revenue figure was made by Europe (excluding Sweden) — last year it brought HANSA BIOPHARMA AB 178.83 M MXN, and the year before that — 159.40 M MXN.